Ashford Capital Management Inc Bristol Myers Squibb CO Transaction History

Ashford Capital Management Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 16, 2021	SELL	$57.74 - $65.43 $228,073 - $258,448	-3,950 Closed	0 $0
Q3 2020 Nov 16, 2020	SELL	$57.43 - $63.64 $57,430 - $63,640	-1,000 Reduced 20.2%	3,950 $238,000
Q2 2020 Aug 17, 2020	BUY	$54.82 - $64.09 $271,359 - $317,245	4,950 New	4,950 $291,000
Q1 2019 May 15, 2019	SELL	$45.12 - $53.8 $297,611 - $354,864	-6,596 Closed	0 $0
Q2 2017 Aug 21, 2017	BUY	N/A	6,596	6,596 $368,000

2,444

1.51B

29.7M

32.1M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $119B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Ashford Capital Management Inc, based on Form 13F filings with the SEC.

Stay updated on Ashford Capital Management Inc with notifications on news.